Carregant...
A Novel Immunoassay for the Quantization of CYFRA 21–1 in Human Serum
BACKGROUND: Cytokeratin 19 fragment antigen (CYFRA 21–1) is used to diagnose and monitor neoplasms. However, the main disadvantages of the currently available CYFRA 21–1 assays include heterogenous technology, being time‐consuming, and having low through‐put with low insensitivity. This study invest...
Guardat en:
| Publicat a: | J Clin Lab Anal |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2013
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6807541/ https://ncbi.nlm.nih.gov/pubmed/23852784 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcla.21597 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|